製品名:4-methyl-3-[(1r,3s)-1-(3-bromophenyl)-3-methylcyclobutyl]-4,5-dihydro-1H-1,2,4-triazole-5-thione

IUPAC Name:4-methyl-3-[(1r,3s)-1-(3-bromophenyl)-3-methylcyclobutyl]-4,5-dihydro-1H-1,2,4-triazole-5-thione

CAS番号:2573776-89-1
分子式:C14H16BrN3S
純度:95%+
カタログ番号:CM1075491
分子量:338.27

包装単位 有効在庫 価格(USD) 数量

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:2573776-89-1
分子式:C14H16BrN3S
融点:-
SMILESコード:CN1C([C@]2(C[C@@H](C)C2)C3=CC(Br)=CC=C3)=NNC1=S
密度:
カタログ番号:CM1075491
分子量:338.27
沸点:
MDL番号:
保管方法:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Column Infos

NX-1607
Nurix disclosed the discovery and structure of NX-1607 in the First Time Disclosures session at the American Chemical Society Spring 2024 meeting in New Orleans, LA. This is the first inhibitor of CBL-B to advance into clinical studies and a prime example of Nurix’s ability to target previously undruggable E3 ligases.

Related Products